Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists

Frontiers in Immunology- Switzerland

doi 10.3389/fimmu.2019.02450

Full Text

Abstract

Available in

Categories

Date

October 15, 2019

Authors

Amanda B. Macedo

Camille L. Novis

Publisher

Frontiers Media SA

Related search

Harnessing the Immune System to Fight Cancer With Toll-Like Receptor and RIG-I-like Receptor Agonists

Pharmacological Research

English

Tissue Factor and Toll-Like Receptor (TLR)4 in Hyperglycaemia-Hyperinsulinaemia

Thrombosis and Haemostasis

English

Toll-Like Receptor (TLR)2 and TLR4 Agonists Regulate CCR Expression in Human Monocytic Cells

Journal of Immunology

English

Targeting Toll-Like Receptor-4 to Tackle Preterm Birth and Fetal Inflammatory Injury

Clinical and Translational Immunology

English

On the Edge: Targeting Toll-Like Receptor 2 in Ischemia/Reperfusion Injury

Circulation: Cardiovascular Interventions

Cardiovascular Medicine

English

Association Between Toll-Like Receptor 4 (Thr399Ile and Asp299Gly), Toll-Like Receptor 2 196-174 Deletion Polymorphisms With Cryptosporidiosis

Journal of Biosciences and Medicines

English

Toll-Like Receptor System and Endometriosis

Journal of Obstetrics and Gynaecology Research

English

Methamphetamine Inhibits Toll-Like Receptor 9-Mediated Anti-Hiv Activity in Macrophages

AIDS Research and Human Retroviruses

Infectious Diseases

English

Toll-Like Receptor 2 (TLR2)

Science-Business eXchange

English